HC Wainwright Reiterates Neutral Rating for Oramed Pharmaceuticals (NASDAQ:ORMP) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Oramed Pharmaceuticals Inc (NASDAQ:ORMP) Sees Large Increase in Short Interest themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report) crossed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $2.61 and traded as low as $2.17. Oramed Pharmaceuticals shares last traded at $2.23, with a volume of 80,966 shares. Analyst Ratings Changes Separately, StockNews.com began coverage on […]
Oramed Pharmaceuticals Inc. (NASDAQ:ORMP – Get Free Report)’s share price passed below its 200-day moving average during trading on Thursday . The stock has a 200-day moving average of $2.66 and traded as low as $2.21. Oramed Pharmaceuticals shares last traded at $2.32, with a volume of 161,057 shares traded. Wall Street Analysts Forecast Growth […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.